Evaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics

Clinical trial NCT02336269 · UNKNOWN

Trial details

NCT number: NCT02336269
Sponsor: Primex Clinical Laboratories, Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Patients on Medications Metabolized Via CYP450

Start date: 2013-10-01
Primary completion: 2017-10-01
Enrollment: 100000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.